Literature DB >> 23207623

Could a possible crosstalk between AMPK and TGF-β signaling pathways be a key player in benign and malignant salivary gland tumors?.

Nastaran M Ghahhari1, Hamed M Ghahhari, Mehdi Kadivar.   

Abstract

BACKGROUND: Salivary gland tumors (SGTs) are known for their specific heterogeneity and ambiguous outcome for the affected patients. The LKB1 and SMAD4 genes are pivotal components of important signaling pathways, including AMPK and TGF-β. To our knowledge, no study has reported an association between the expression levels of these genes in SGTs. The expression levels of LKB1 and SMAD4 were evaluated to clarify their possible crosstalk in SGTs.
MATERIALS AND METHODS: A total of 50 fresh tissue specimens were obtained from patients with SGTs, including pleomorphic adenoma (PA), Warthin's tumor (WT), intermediate grade mucoepidermoid carcinoma (MEC), salivary duct carcinoma (SDC), and carcinoma ex pleomorphic adenoma (CexPA), as well as 8 normal samples. Quantitative real-time polymerase chain reaction was performed for all samples with specific primers.
RESULTS: Data were analyzed using statistical methods. PA, WT, MEC, and SDC showed a significant decrease in LKB1 levels, but the gene was up-regulated in CexPA. SMAD4 was overexpressed in all samples.
CONCLUSION: The results suggest a possible link between downregulation of LKB1 and overexpression of SMAD4 in SGTs. LKB1 depletion leads to upregulation of SMAD4, promoting epithelial-mesenchymal transition in tumor cells. Therefore, LKB1 and SMAD4 could be key players in inducing tumor heterogeneity in SGTs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23207623     DOI: 10.1159/000345131

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  2 in total

1.  Inactivation of the LKB1-AMPK signaling pathway does not contribute to salivary gland tumor development - a short report.

Authors:  Natascha Cidlinsky; Giada Dogliotti; Tobias Pukrop; Rudolf Jung; Florian Weber; Michael P Krahn
Journal:  Cell Oncol (Dordr)       Date:  2016-08-01       Impact factor: 6.730

Review 2.  Role of Smad signaling in kidney disease.

Authors:  Yanhua Zhang; Songyan Wang; Shengmao Liu; Chunguang Li; Ji Wang
Journal:  Int Urol Nephrol       Date:  2015-10-03       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.